PatientsVille.com Logo

Diabetes and Junevia

PatientsVille

Diabetes Symptoms and Causes

Diabetes is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose comes from the foods you eat. Insulin is a hormone that helps the glucose get into your cells to give them energy. With type 1 Diabetes, your body does not make insulin. With type 2 Diabetes, the more common type, your body does not make or use insulin well. Without enough insulin, the glucose stays in your blood. You can also have preDiabetes. This means that your blood sugar is higher than normal but not high enough to be called Diabetes. Having preDiabetes puts you at a higher risk of getting type 2 Diabetes.

Over time, having too much glucose in your blood can cause serious problems. It can damage your eyes, kidneys, and nerves. Diabetes can also cause heart disease, stroke and even the need to remove a limb. Pregnant women can also get Diabetes, called gestational Diabetes.

Blood tests can show if you have Diabetes. One type of test, the A1C, can also check on how you are managing your Diabetes. Exercise, weight control and sticking to your meal plan can help control your Diabetes. You should also monitor your blood glucose level and take medicine if prescribed.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for diabetes

diabetes treatment research studies

Junevia clinical trials, surveys and public health registries


Find Drug Side Effect reports



Junevia Side Effects

Pancreatitis Acute (17)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Dont get discouraged, I am 21 years old and got diagnosed with diabetes when i was 15. I hated it for a little while then i thought well i have to live with it so i better make the best of it. I, just like anyone, wanted to live an ordinary teen life

I am 14 and type one diabetic, and i just want it to go away so i can live a normal happy life, i would like to drink to see what its like (typical teen) but i really dont want diabetes , so i don't really care about it, my mum and dad get worried be

I am a <b>Cancer patient with Diabetes Type 2 and dependent on Human Insulin for many years. I am on Insulin on two times a day. I was on chemotherapy several times and many cycles. My sugar level is still unconrolled.&n

I received an injection of zostavax in August 2005 and approx 3 months later I was diagnosed with TYPE 1 DIABETES. No one in my entire family history has ever had diabetes. I was and still am 185 lbs.

I was diagnosed with diabetes 2 years ago and have been taking one diabex xr tablet per day with dinner . Since then I have had gastrointestinal problems which only ease with gastro stop tabletswhen needed. I am frightened to goan

Is frequent urination type 1 diabeetus connected in any way? I know that type 1 diabetics urinate alot or more when having high blood sugars, ok which I have had none of late. Thanks for your input.

Wow i am sorry to hear this. i am 44 years old and was diagnosed with type 1 diabetes at 17 years old, very late for juvenile. my brother also has had type 1 since he was 11 and he is 48 now. we live a perfectly normal life for the most. we both have

Hello, I was given Azastin or Avastin for macular edema. I also have retinopathy from diabetes. I was given this shot in my eye in April of this yr. Within 2 days, I had cellulitis in both legs. Horrible pain. Dark red all over from my knees to my

Another thing, can a patient with diabetes type 1 and previously suffered and recovered from Multiple sclerosis ( M-S ) use Spasfon ???

Before I took atenolol i had a perfect glucose numbers after taking it I came down with diabetes. I am 102lbs, 4'11, have always eaten healthy, exercise my whole life. I am 76. I was taken off atenolol after5 years...and NO ONE in my family for ge

Burning sensation, confusion, mental states changes, lethargy, chest pain, pain, communication difficulty.88 years old with astma, high blood pressure, diabetes, prostate enlargement,

Can I take ciprofloxacin with my medicines for diabetes

Can taking of Neuleptil unregularely by father couse a 1st level diabetes for his son?

Dont get discouraged, I am 21 years old and got diagnosed with diabetes when i was 15. I hated it for a little while then i thought well i have to live with it so i better make the best of it. I, just like anyone, wanted to live an ordinary teen life

Good effects on diabetes. weight reduction -rapid and moderate to excessive hair fall after 3 months of use

Hi, I'm 21 years old, recently released from the hospital for possible brain infection (took a variety of antibiotics and anti-virals). I have possible diabetes and I recently developed tinnitus I think, and the possible causes for it is my prolonged

I am 14 and type one diabetic, and i just want it to go away so i can live a normal happy life, i would like to drink to see what its like (typical teen) but i really dont want diabetes , so i don't really care about it, my mum and dad get worried be

Diabetes Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Diabetes and Partnership: Evaluation of a Diabetes Education Module
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Partnership
Outcome Measures: Change from baseline in Diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general Diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
2 Recruiting Diabetes and Sports: Evaluation of a Diabetes Education Module
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Sports
Outcome Measures: Change from baseline in Diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in physical activity on the International Physical Activity Questionnaire (IPAQ) at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general Diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up;   Change from baseline in hypoglycemia awareness at the 2-week and 6-month follow-up;   Change from baseline in self-care behaviors at the 2-week and 6-month follow-up
3 Recruiting Diabetes and Social Issues: Evaluation of a Diabetes Education Module
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Social Issues
Outcome Measures: Change from baseline in Diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general Diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
4 Recruiting Diabetes and Travel: Evaluation of a Diabetes Education Module - a Randomized Controlled Trial (PRIMO_Travel)
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Travel
Outcome Measures: Change from baseline in Diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general Diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
5 Recruiting Lifestyle Intervention for Treatment of Diabetes
Conditions: Type 2 Diabetes;   Overweight;   Obesity
Interventions: Behavioral: Community Lifestyle Weight Loss (LWL);   Behavioral: Diabetes Self Management (DSM)
Outcome Measures: Predicted Cardiovascular Risk;   Hemoglobin A1c;   Blood Pressure;   Lipids;   Weight Change
6 Recruiting Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
Conditions: Major Depressive Disorder;   Minor Depressive Disorder;   Sub-Threshold Depression;   Diabetes Mellitus
Interventions: Behavioral: Step 1: Diabetes-Specific CBT (5 group sessions);   Behavioral: Step 2: Depression-Specific CBT (6 single sessions);   Behavioral: Step 3: Referral to Psychotherapist and/or Psychiatrist;   Behavioral: Standard Diabetes Education
Outcome Measures: Depressive Mood - Hamilton Rating Scale for Depression (HAMD);   Diabetes-Related Distress - The Problem Areas in Diabetes Questionnaire (PAID);   Psychological/ Emotional Well-Being - The WHO-5 Well-being Index (WHO-5);   Health-Related Quality of Life - The Short Form-36 Health Survey (SF-36);   Diabetes Self-Care Behavior - The Summary of Diabetes Self-Care Activities Measure (SDSCA);   Glycaemic Control (HbA1c);   Health-Related Quality of Life - The EuroQol-5D (EQ-5D);   Diabetes Self-Care Behavior - The Diabetes Self-Management Questionnaire (DSMQ)
7 Recruiting Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients
Condition: Diabetes
Intervention: Procedure: Blood withdrawal
Outcome Measures: Levels of gene expression for UCP2 (RQ);   Improved metabolic state
8 Not yet recruiting Effectiveness Study of Interactive Web Application for Problem Solving in Diabetes Management
Condition: Diabetes Mellitus
Interventions: Behavioral: Early Mobile Diabetes Detective (MoDD);   Behavioral: Late Mobile Diabetes Detective (MoDD)
Outcome Measures: Change in HgA1c;   Change in Score on the Diabetes Problem-Solving Inventory (DPSI);   Change in Score on the Summary of Diabetes Self-Care Activities Questionnaire (SDSCA);   Change in Score on Problem Areas in Diabetes Scale (PAID);   Change in Score on the Diabetes Self-Efficacy Scale (DSES);   Change in Score on the Patient Health Questionnaire-2 (PHQ-2);   Change in Fasting Blood Glucose Level;   Change in Total Cholesterol;   Change in Blood Pressure;   Change in High-Density Lipoprotein;   Change in Low-Density Lipoprotein
9 Recruiting Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Other: Transition Coordinator
Outcome Measures: The proportion of subjects who fail to attend at least one outpatient adult endocrinology visit during the second year after transition to adult Diabetes care.;   In the 2 years of transfer to adult care-Frequency of A1C testing and mean levels Frequency of retinal exam microalbumin to creatinine ratio fasting lipid profile and foot exam testing Rate of hospitalization/ER visits for acute complications of Diabetes
10 Recruiting Non-Alcoholic Fatty Liver Disease in Gestational Diabetes
Condition: Gestational Diabetes Mellitus in Pregnancy
Interventions: Other: Subjects with Gestational Diabetes;   Other: Controls without Gestational Diabetes
Outcome Measures: Percentage of patients with NAFLD and gestational Diabetes.;   Insulin sensitivity expressed as the Matsuda Index, measured during an oral glucose tolerance test.
11 Not yet recruiting Web-Based Collaborative Care for Patients With Diabetes and Depression
Conditions: Diabetes Mellitus, Type 2;   Depression
Interventions: Device: web-based collaborative care;   Other: wait-list;   Behavioral: usual Diabetes outpatient care
Outcome Measures: Change in Patient Health Questionnaire-9 items (PHQ-9) score;   Change in biochemical index;   Chang in quality of life (EuroQol-5D)score;   Change in Diabetes-specific stress;   Change in Health behaviours;   Change in general self-efficacy
12 Unknown  Diabetes Support Project: Couples Intervention
Condition: Type 2 Diabetes
Interventions: Behavioral: Telephone support and behavior change;   Other: Diabetes self-management education
Outcome Measures: Blood glucose control (hemoglobin AIc);   Measures of behavior change (diet, physical activity);   Diabetes-related quality of life outcome (distress);   BMI/Waist circumference
13 Unknown  A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Conditions: Type 2 Diabetes;   Major Depressive Disorder
Interventions: Behavioral: Diabetes and depression intervention;   Behavioral: Diabetes intervention
Outcome Measures: Glycosylated Hemoglobin;   Quick Inventory of Depressive Symptoms - Self Report
14 Unknown  Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Diabetes Transitions Tool Kit
Outcome Measures: Glycemic Control;   Diabetes Distress;   Diabetes Self-Management;   Unplanned Readmission or ED visit
15 Not yet recruiting Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care
Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Culturally tailored Diabetes program
Outcome Measures: Change in A1C or blood pressure (systolic or diastolic blood pressure);   change in fasting lipid profile;   Change in weight or waist circumference;   change in health status
16 Unknown  Parental Management of Young Children's Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Parental Support;   Behavioral: Diabetes Education
Outcome Measures: Glycemic variability;   Parent Quality of Life;   Child Quality of Life;   Hemoglobin A1C
17 Unknown  Diabetes Mellitus Community Based Screening in Minority Populations
Conditions: Type II Diabetes;   Diabetes Mellitus
Interventions: Behavioral: Education on risk factors for Type II Diabetes;   Behavioral: Education on Type II Diabetes;   Behavioral: Education on regular visits to a Primary Care Provider
Outcome Measure:
18 Recruiting Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth
Condition: Diabetes
Intervention: Behavioral: Together on Diabetes-Hopkins
Outcome Measures: Change in percent of total calories from fat from baseline through 12 months follow-up;   Increased physical activity levels between baseline and 12 months follow-up;   Decreased body mass index between baseline and 12 months follow-up;   Improvement in point of care Hemoglobin A1C level between baseline and 12 month follow-up;   Decrease in waist circumference between baseline and 12 months follow-up;   Decreased blood pressure between baseline and 12 months follow-up;   Improvements in youth Diabetes knowledge test score between baseline and 12 months follow-up;   Improved score on Pediatric quality of life assessment (Ped-QL) between baseline and 12 months follow-up;   Increased numbers of family members involved in Diabetes support care between baseline and 12 months follow-up;   Increased numbers of individuals having been screen for Diabetes between baseline and 12 months follow-up
19 Recruiting A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community
Condition: Diabetes
Interventions: Behavioral: Experimental: Diabetes Self Management;   Behavioral: General Health Education
Outcome Measures: Hemoglobin A1C (HbA1C);   Behavioral outcomes of self-reported management of Diabetes;   Health-related quality of life;   Diabetes knowledge;   Family support;   Diabetes Self-efficacy
20 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:
Outcome Measures: Development of type 1 Diabetes;   Metabolic and Autoantibody Assessments